Skip to main content

Market Overview

16 Healthcare Stocks Moving In Friday's Pre-Market Session

Share:

Gainers

  • Ekso Bionics Holdings, Inc. (NASDAQ: EKSO) stock increased by 19.7% to $0.67 during Friday's pre-market session. The market cap stands at $69.4 million. The most recent rating by Cantor Fitzgerald, on September 06, is at Overweight, with a price target of $1.00.
  • Durect, Inc. (NASDAQ: DRRX) stock surged 15.1% to $1.91. The market cap stands at $124.7 million. The most recent rating by Cantor Fitzgerald, on September 06, is at Overweight, with a price target of $5.00.
  • Neon Therapeutics, Inc. (NASDAQ: NTGN) shares increased by 12.4% to $3.27. The market cap stands at $134.2 million. The most recent rating by Baird, on July 26, is at Outperform, with a price target of $15.00.
  • Kadmon Holdings, Inc. (NYSE: KDMN) shares moved upwards by 9.1% to $2.70. The market value of their outstanding shares is at $135.8 million. The most recent rating by Cantor Fitzgerald, on September 06, is at Overweight, with a price target of $8.00.
  • Myovant Sciences, Inc. (NYSE: MYOV) shares moved upwards by 8.8% to $8.75. The market cap seems to be at $782.9 million. The most recent rating by Goldman Sachs, on August 28, is at Buy, with a price target of $20.00.
  • DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI) shares rose 6.5% to $0.65.
  • CannTrust Holdings, Inc. (NYSE: CTST) stock moved upwards by 4.5% to $1.84. The market cap seems to be at $555.7 million.
  • Mallinckrodt, Inc. (NYSE: MNK) stock rose 4.4% to $1.66. According to the most recent rating by BMO Capital, on September 05, the current rating is at Market Perform.
  • DBV Technologies, Inc. (NASDAQ: DBVT) stock rose 2.7% to $10.21. The most recent rating by Goldman Sachs, on June 17, is at Buy, with a price target of $14.00.
  • Livongo Health, Inc. (NASDAQ: LVGO) stock rose 1.8% to $26.00. The market cap stands at $4.0 billion. The most recent rating by Morgan Stanley, on August 28, is at Overweight, with a price target of $42.00.

 

Losers

  • Viveve Medical, Inc. (NASDAQ: VIVE) shares plummeted 10.2% to $0.09 during Friday's pre-market session. According to the most recent rating by Ladenburg Thalmann, on July 24, the current rating is at Neutral.
  • Zafgen, Inc. (NASDAQ: ZFGN) shares fell 5.7% to $0.66. The market cap seems to be at $96.7 million. The most recent rating by Wedbush, on September 06, is at Neutral, with a price target of $0.78.
  • Edesa Biotech, Inc. (NASDAQ: EDSA) stock declined 3.9% to $5.75. The market value of their outstanding shares is at $39.3 million.
  • Turning Point, Inc. (NASDAQ: TPTX) stock decreased by 2.7% to $45.71. The market value of their outstanding shares is at $1.0 billion.
  • uniQure, Inc. (NASDAQ: QURE) shares plummeted 2.4% to $46.50. The market cap stands at $290.3 million. According to the most recent rating by Guggenheim, on July 30, the current rating is at Neutral.
  • Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) stock decreased by 1.5% to $98.79. The market cap stands at $24.1 billion. The most recent rating by Credit Suisse, on September 06, is at Outperform, with a price target of $146.00.
 

Related Articles (ALXN + CTST)

View Comments and Join the Discussion!

Posted-In: Healthcare Stocks Pre-Market MoversNews Movers & Shakers Pre-Market Outlook Markets Movers Trading Ideas General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com